Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Chromatography Releases from Waters and Thermo Fisher

Premium

Waters this week introduced a number of new products for protein and glycan analysis, including its new Acquity UPLC CSH130 C18 columns, its XSelect HPLC CSH130 C18 columns, and three GlycoWorks kits for glycan labeling and sample prep.

The CSH130 columns are intended for peptide mapping and proteomics applications and feature Waters' Charged Surface Hybrid particle technology which allows the columns to be used with a weaker acid modifier to obtain greater resolving power and sensitivity in LC-MS, the company said.

The GlycoWorks kits include two prep kits – one for high throughput and one for single use – and a labeling kit for use with released glycans.


Thermo Fisher Scientific this week launched its Dionex Ultimate 3000 Biocompatible Rapid Separation system.

The system supports high resolution separations for R&D work along with high throughput QA/QC analyses on the same platform, at pressures up to 15,000 psi, the company said.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.